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Specific  chromosomal  abnormalities  found  in  rat  leukemia  induced  with 
7,12-dimethylbenz(a)anthracene(7,12-DMBA)(1,2)  are important  in research 
on  chemical  carcinogenesis  since they were  shown  to  affect cell differentiation 
(3). 
Recently,  other  aromatic  hydrocarbons  such  as  7,8,12-trimethylbenz(a)- 
anthracene(7,8,12-TMBA)  were shown capable of inducing leukemia and some 
other  cancers  in  the  rodent  (4-6).  They  were  also  proved  to  elicit  adrenal 
necrosis  in the rat  (7,  8).  Therefore,  they seem to  act  on an  animal  cell in the 
same way as their  prototype  7,12-DMBA  does.  Thus,  it seems  worthwhile  to 
study chromosomes of rat leukemia induced with these compounds. 
Materials and Methods 
Male and female rats of noninbred Long-Evans strain maintained and raised in this lab- 
oratory were used.  They were fed a  commerical ration  (Rockland  diet),  received water ad 
libitum, and were kept in an air-conditioned room at  25  4- 2°C. 
A  lipid  emulsion  of  7,8,12-TMBA  I  (0.5%,  w/w)  or  6,8,12-TMBA  2  (0.5%,  w/v)  was 
injected into the caudal vein. The first pulse dose was given 21-27 days after birth. A dose of 
35 mg/kg body weight of each compound was given 4-6 times at intervals of 10-14 days (6). 
Leukemia rats were killed under ether anesthesia at the terminal stage of the disease.  All the 
leukemia examined showed the macroscopic appearance of hepatic type which was described 
in the previous papers  (6, 8). 
Since there was  no striking difference of karyotype  of the leukemia cells between bone 
marrow and liver or spleen in 7,12-DMBA-induced leukemia (2), mostly chromosome analysis 
of bone marrow cells was performed in the present experiment. Approximately 40 cells were 
analyzed in each case and at least five cells in a stemline were examined for karyotype. The 
nomenclature of chromosomes in the present study has been described in previous papers (1, 2). 
* This  work  was  supported  by  grants  from  the  American  Cancer Society,  the  Jane 
CoflSn Childs Memorial Fund  for Medical Research, and United States Public Health Serv- 
ice, National Institutes of Health (No. CA 11603). 
1 Lipid emulsion of 7,8,12-TMBA was prepared by P. E. Schurr, The Upjohn Company, 
Kalamazoo, Mich. 
~ Lipid emulsion of 6,8,12-TMBA  was prepared  in this laboratory using the technique 
described in reference 7. 
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RE SULTS 
Among the 62 leukemias induced with 7,8, 12-TMBA and the 2 induced with 
6,8,12-TMBA, 15 leukemias (23.4 %) were shown to have the stemline(s) with 
chromosomal abnormalities involving the largest telocentric chromosome  (C-1 
chromosome).  An  additional  eight  leukemias  revealed  various  other  chro- 
mosomal abnormalities. 41 leukemias (64.1%) had a predominant stemline with 
normal karyotype. 
Leukemias with C-1 Trisomic Anomaly (Table I) 
Leukemia  T-l.--Modal chromosome number was  42.  Karyotype analysis of  the 
modal cells revealed the presence of an extra long telocentric marker chromosome and 
monosomy of one member of C-2-C-9 chromosomes (Fig. 2). The length of the large 
marker chromosome was almost equivalent to the sum of C-1 and C-8-size chromo- 
some, and this leukemia cell was considered to have C-1 trisomy of translocation type, 
as was described and named translocation  type 1 in one leukemia induced with 7,12- 
DMBA (2).  16 other ceils with different chromosome number showed  the same chro- 
mosomal abnormality although 12 cells with 43 chromosomes had an additional pres- 
ence of one of A-group chromosomes. 
Leukemias T-5 and T-6.--The predominant stemline cell had typical C-1  trisomy 
(Fig. 1). T-5 had another stemline with normal karyotype. 
Leukemia~  T-16 and T-18.--Both  leukemias consisted of two stemlines: one with 
normal karyotype and the other with C-I trisomy of translocation  type 2  (Fig. 3)  al- 
ready described in many leukemias induced with 7,12-DMBA (1, 2). 
Leukemia T-24.--An almost pure stemline with typical C-] trisomy was found. 
Leukemia T-27.--39  cells had a  large chromosome which appeared like the large 
metacentric marker chromosome in translocation type 2 C-1 trisomy (Fig. 4). However, 
considering that the B-1 chromosome in these cells was monosomic, it is probable 
that this marker was formed by translocation of an extra C-1 to the long arm of B-1 
chromosome. This new translocation type has been found in one of the 7,12-DMBA- 
induced leukemias  3 and was designated translocalion type 5. This leukemia was accom- 
panied with other chromosomal abnormalities: each cell had trisomy of B-2  and 23 
cells with 41 and 42 chromosomes had monosomy of A-7 chromosome. 
Leukemia T-32.--This leukemia was characterized by having typical trisomy of C-1 
chromosome, and an accompanied monosomy of B-3 was found in 5 cells with 42 chro- 
mosomes. Another modal cell with 42 chromosomes had normal karyotype. 
Leukemia T-42.--7 ceils with chromosome number 41 and 42 had translocation type 2 
C-1 trisomy and 3 cells with 43 chromosomes had typical C-1 trisomy. 19 cells with 42 
chromosomes had normal karyotype. 
Leukemia T-50.--AI1 the cells examined had typical trisorny of C-1 chromosome.  17 
cells with 41, 42, and 43 chromosomes had monosomic B-5 chromosome and a small 
metacentric marker which from its appearance and the abnormal characteristics of the 
short arms of one B-3 was thought to be formed by arm exchange between B-3 and B-5 
chromosomes.  Three other cells with 40 and 42 chromosomes  had small subtelocentric 
3 Sugiyama, T. Unpublished data. TAKETOSHI  SUGIYAMA AND  ~'ILOMENA  P.  BRILLANTES 
TABLE  I 
Leukemias with Abnorma~ C-1 Chromosome Constitution* 
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Leu-  Total  Chromosome No. 
kemia  Sex  cells 
ana-  I  No.  lyzed  40  41  42  43  44  45  46  I 
r-1  F  38  2a  2a  17a, 3  12a 
i 
r-5  F  40  la, 1  2  la, 14  17a,  1  2a  la 
F-6  F  40  2a  3a, 8  25a 
F-12  F  40  5b  5b  27b, 1  2b 
r-161F  40  la  la  20a, 18 
F-18  F  40  la  26a, 13 
F-24  ; F 
F-27  F 
F-28  F 
F-32  F 
40  la  4a, 2  31a 
40  3a  20a, 1  14a 
40  2b  2b, 1  29b, 3  1 
40  la, 1  5a, 22  9a 
F-36  M  40  lb  34b, 5 
7-42  F  40  lb, 3  2a, 5  5a, 19  3a 
F-49  F  40  lb  lb  38b 
r-50  F  40  la  la  14a  24a 
?-61  F  40  lb  35b  la, 2c 
la  la 
la 
la 
2a 
lc 
] 3N  4N 
1  1 
I 
1 
I 
i  1 
i 
I1  1 
I  2 
I 
Main stemline (s) 
% 
C-1  trisomy:  86.[ 
C-1  trisomy:  55.( 
2N: 35.0 
C-1 trisomy: 80.0 
Long C-l: 97.5 
C-1 trisomy: 55.0 
2N: 45.0 
C-1 trisomy: 67.5 
2N: 32.5 
C-1 trisomy: 92.5 
C-1 trisomy: 97.5 
Long C-I: 82.5 
Long C-1 : 37.5 
2N: 55.0 
C-1 trisomy: 87.5 
2N: 47.5 
C-1 trisomy: 27.5 
Long C-1 : 100.0 
C-1 trisomy: 100.( 
Long C-l: 90.0 
* a, cells with C-1 trisomy. 
b, cells with long C-1. 
c, cells with C-1 tetrasomy. 
2N, the stemline with normal karyotype. 
Small Cell Populations.--As is seen in Tables I, III, and IV, a  small number of C-1 
trisomic cells were found in leukemias T-23, T-29, T-54, T-56, and T-61, and a few C-1 
tetrasomic cells were detected in leukemia T-61. All of them were typical trisomy or 
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marker chromosomes which were possibly formed by translocations  among B-3, B-4, 
B-5, and one C-group chromosome. 
Leukemias with a Long C-1 Chromosome  (Tables I  and H) 
Four leukemias T-12, T-28, T-36,  and T-61  induced with 7,8,12-TMBA  and one 
induced with 6,8,12-TMBA, T-49, were shown to have a characteristic  chromosomal 
abnormality  which could be referred  to  as long  C-1  (Figs.  5-8).  This anomaly  con- 
sisted of a  striking elongation of one C-1  chromosome.  Four long C-1  chromosomes 
found in T-12, T-28,  T-36,  and T-49 had no structural  abnormality  apart from the 
length, while the one found in T-61  had satellite  chromosomes at the distal end. By 
comparison  with  the  long  arms  of  B-1  chromosomes,  the  corresponding  C-1  chro- 
mosomes revealed the original length. As is dear from  Table II, the degree of elonga- 
TABLE  II 
Degree of Chromosome Elongation in Long C-1  Chromosome Abnormality* 
Leukemia No.  Carcinogen used 
Elongation rate (= long C-l/C-l) 
Mean =t= s. 
T-12  7,8,12-TMBA  1.349  :t=  0.087 
T-28  7,8,12-TMBA  1.322  4-  0.078:~ 
T-36  7,8,12-TMBA  1.271  -4-  0.040§ 
T-49  6,8,12-TMBA  1.263  4-  0.067§ 
T-61  7,8,12-TMBA  1.590  4-  0.125§ 
* The values represent the ratio of long C-1 to short (normal size)  C-l, measured in eight 
well-spread metaphase cells. 
J~ Difference from the value in T-12 not significant. 
§ Difference from the value in T-12 significant in the range of 0.05  >  p  >  0.02. 
tion  was  different  from  case  to  case.  By  statistical  study,  at  least  three  classes  of 
elongation  rate  were  identified:  1.26,  1.35,  and  1.59.  In  every  case,  the  remaining 
chromosomal members  seemed perfect.  The above five leukemias  had  the long C-1 
cells as  the predominant  stemline, although  there were also cases in which  they re- 
mained in a  small population. The elongation rate  of C-1  chromosome in these cells 
was:  1.15  (T-7),  1.23  (T-38),  1.47  (T-48),  1.19  (T-54),  1.12  (T-56),  1.18  and  1.19 
(T-58),  and  1.19  and  1.11  (T-60).  They  were classified as  a  "long C-I" cell because 
one C-1 chromosome was apparently longer than another C-1 chromosome and at the 
same time it was longer than the length of C-1 expected from the mean length of two 
B-1  chromosomes.  However,  considering  the  fact  that  each corresponding  chromo- 
some complement  often  shows  a  different size as  a  preparation  artifact,  it was  not 
clear whether  all the cells listed above were cells with long C-1  abnormality,  and it 
was also impossible to presume  the elongation rate of C-1  chromosome from a  meas- 
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Leukemias with Other Chromosomal  Abnormalities (Table III) 
Leukemia  T-3.--This leukemia which had 41  modal chormosome number showed 
the deletion of one member of A-group chromosome and one or a pair of B-3, B-4, and 
B-5 chromosomes, and the presence of three or four markers. One marker was a  telo- 
TABLE  III 
Leukemias with Various Other Chromosomal Abnormalities* 
Leu- 
kemia  Sex 
No. 
T-3  M  25 
41  42 
14d, 4  ld, 6 
T-26  F  9  1  8d 
43  44  48 
T-45  M  40  3d  20d, 15  ld, 1 
T-63  F  40 
51  52  53 
T-64  F  40  4d  7d  24d 
.~N  56  60 
T-19  F  26  1  ld  ld 
2N  3N  72 
T-55  M  40  26  1  1 
42  43  49 
T-56  F  40  lb, 4  la  2 
16d 
54 
5d 
61 
3d 
73 
1 
57 
ld 
Chromosome number 
ld  ld 
61  62 
15d  7d 
Stemline with chromosome 
abnormalities (%) 
Small  subtelo-  and  sub- 
metacentric  markers: 
60.0 
Small metacentric marker: 
88.9 
Large  submetacentric 
marker: 100.0 
Medium  metacentric 
marker: 100.0 
Two  subtelocentric 
markers: 100.0 
Triploid  with  a  minute: 
96.2 
Hypotetraploid: 30.0 
Triploid  with  a  minute 
and two submetacentric 
markers: 80.0 
a, cells with C-1 trisomy, b, cells with long C-1. d, cells with other marker(s). 
centric smaller than Y  chromosome. The other three markers, from their size, seemed 
to  be  formed  by  translocations  among  the  missing  chromosome  complements.  The 
modal cells with 41 chromosomes consisted of cells with various combinations of the 
above chromosome abnormalities. 
Leukemia T-26.--This leukemia was granulocyfic leukemia with peroxidase-positive 
granules. Almost 5% of the ceils had eosinophilic granules. Only nine metaphases were 
obtained in the chromosome specimens and eight cells had a  metacentric chromosome 338  CYTOGENETIC  STUDY  OF  LEUKEMIA 
of a  size of A-l-2 chromosomes.  A detailed analysis showed that this was an extra 
chromosome having a slightly different arm structure from those of A-1 or A-2. 
Leukemia T-45.--Tbe presence of a large submetacentric marker and monosomy of 
B-1 chromosome characterized this leukemia. The long arm of this marker was almost 
equivalent to the long arm of B-1  chromosome. Therefore,  this marker is related with 
monosomy of B-1  chromosome. The same abnormality was already described in one 
leukemia induced with 7,12-DMBA (Leukemia No. 23 in reference 2). 
Leukemia T-63.--This leukemia had two marker chromosomes: one medium meta- 
centric chromosome and one B-l-like subtelocentric marker with a  slightly shorter 
long arm. The cells with 45 chromosomes had an additional subtelocentric chromosome 
as large as B-5 chromosome with a little different structure. 
Leukemia T-64.--Two  subtelocentric markers were  present in this leukemia: one 
similar with B-1  but with a  shorter long arm and the other a  large subtelocentric 
marker with a prominent satellite structure. B-5 monosomy was found. Trisomies of 
B-3 and B-4, the increase of 4 chromosomes in both A- and C-groups made the modal 
chromosome number of this leukemia 53. 
Leukemia T-19.--Karyotype analysis of this leukemia showed the triploid character 
and the presence of a minute chromosome.  One member from both the A and C groups 
was lost constituting the chromosome number of 62. 
Leukemia  T-55.--This leukemia had two modal cells: one was of normal karyotype 
and the other was hypotetraploid with 75 chromosome number. 
Leukemia T-56.--This leukemia revealed also a triploid nature with an occasional 
presence of a small and a medium submetacentric marker and a minute chromosome. 
One-third of the cells had disomic character regarding the B-1 chromosome. Because of 
various combinations  of the above abnormalities, the modal cells with 61 chromosomes 
did not show a uniform chromosome pattern. 
Small Cell Populations  with  Various Chromosomal Abnormalities.--Some leukemias 
contained a  small cell population with various chromosomal abnormalities. Among 
them were B-3 trisomy in 4 cells with 43 chromosomes in T-10, 7 cells with 43 chromo- 
somes in T-31 in which some member of C-2-9 chromosomes were triplicated. 6 cells in 
T-11 and T-14, 7 cells in T-4, T-9, and T-15, 8 cells in T-30, with 41 chromosomes and 
5 cells with 43 chromosomes in T-57 did not show any consistent chromosome change. 
Cells with various markers were found in leukemias T-10, T-21, T-39, and T-43 (Table 
IV). 
Leukemias with Normal Karyotype (Table IV) 
40 leukemias induced with  7,8,12-TMBA and  1 leukemia (T-44)  induced with 
6,8,12-TMBA had the predominant stemline with normal karyotype. 
DISCUSSION 
The chromosomal abnormalities in rat leukemia induced with  7,8,12-  and 
6,8, 12-TMBA were essentially identical with those in the leukemias induced 
with 7,12-DMBA. The incidence of cell populations with C-1 trisomy was con- 
siderably lower in 7,8, 12-TMBA-induced leukemia. Especially interesting in 
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TABLE  IV 
Leukemia.s with Normal Karyotype 
Leu-  Total 
kemia  Sex  ceils 
No.  Ana- 
lyzed 
T-2  F  29 
T-4  M  40 
T-7  M  40 
T-8  M  40 
T-9  M  40 
T-10  F  40 
T-11  M  40 
T-13  F  40 
T-14  F  40 
T-15  M  40 
T-17  F  40 
T-20  M  40 
T-21  F  25 
T-22  F  40 
T-23  F  40 
T-25  IV[  40 
T-29  F  40 
T-30  F  37 
T-31  M  37 
T-33  F  40 
T-34  M  40 
T-35  F  40 
T-37  M  40 
T-38  F  40 
T-39  F  28 
T-40  F  40 
T-41  F  40 
T-43  F  40 
T-44  M  40 
T-46  F  36 
T-47  F  40 
T48  M  31 
T-51  F  40 
T-52  M  40 
T-53  M  40 
T-54  F  32 
T-57  F  40 
T-58  F  40 
T-59  F  40 
T-60  F  40 
T-62  F  40 
40  41  42 
2  4  20 
3  7  28 
2  4  lb, 33 
1  4  35 
4  7  28 
5  3  23 
3  6  30 
1  38 
1  6  33 
2  7  28 
1  38 
4O 
2  1  20 
2  38 
38 
4  36 
2  1  31 
2  8  25 
3  3  21 
2  3  35 
2  38 
1  39 
2  38 
1  lb, 36 
1  3  2d, 20 
1  1  36 
2  2  33 
1  ld, 4  34 
6  4  30 
3  4  29 
1  39 
3  lb, 26 
2  1  36 
40 
2  37 
3  3  lb, 23 
2  33 
1  1  2b, 36 
1  1  38 
1  2b, 36 
2  1  36 
Chromosome  No. 
43 
1 
1 
5d, 4 
1 
ld 
la 
2a, 3 
7 
2 
1 
5 
1 
44 
ld 
45  46  3N 
la 
Ceils with 
normal 
karyotype 
4N  (%) 
69.0 
70.0 
82.5 
87.5 
70.0 
57.5 
75.0 
95.0 
82.5 
70.0 
95.0 
100.0 
80.0 
95.0 
95.0 
90.0 
77.5 
67.6 
56.8 
87.5 
95.0 
97.5 
95.0 
90.0 
71.4 
90.0 
82.5 
85.0 
75.0 
80.6 
97.5 
83.9 
90.0 
100.0 
92.5 
71.9 
82.5 
90.0 
95.0 
90.0 
90.0 
a, cells with C-1 trisomy, b, cells with long C-1. d, cells with other marker chromosome(s). 340  CYTOGENETIC  STUDY  OF  LEUKEMIA 
mosome abnormality involving the same chromosome complement, long C-I, 
in  7,8,12-  and  6,8,12-TMBA-induced  rat  leukemia.  This  chromosome ab- 
normality was also found in 7,12-DMBA-induced rat leukemias, although the 
cell populations having this abnormality usually did not constitute the predomi- 
nant stemline (9). By measurement of chromosomes of cells from five letlkemias 
with long C-I,  at least three long C-l's  of a  different length were identified. 
Since there was no evidence of interchromosomal chromatid exchange in these 
leukemia karyograms, and several chromatid sites of a normal C-1 chromosome 
have been shown extremelv susceptible to the breaking action of carcinogens  4, 
possibly intrachromosomal chromatid exchanges at these target sites may be 
responsible for the induction of this new chromosome abnormality.  Therefore, 
just  as  C-1  trisomy is a gene-redundant condition,  long C-1  may be  another 
type of chromatid duplication. From this point of view,  this chromosome ab- 
normality would be  another important tool for clarifying the  role of gene im- 
balance in malignant cell transformation suggested in the previous report (3). 
Difference in the incidence of each specific chromosomal abnormality does 
not necessarily mean  a  different mechanism  of chemical carcinogenesis.  The 
difference in toxicity and the different speed of carcinogen action and possibly 
of metabolism might  have produced a  host  condition in which  the  selective 
growth of C-1  trisomy cells was difficult. Although there still remains a possi- 
bility that the three hydrocarbons acted on cells in the same metabolite form, 
the  results  obtained  in  the  present  work  again  suggest  a  very specific and 
simple mechanism leading to the specific chromosomal abnormalities involving 
C-1 chromosome. 
SUMMARY 
Cytogenetic studies on 64 rat leukemias induced with 7,8,12- and 6,8,12- 
trimethylbenz(a)anthracene were performed. Highly distinctive changes were 
found repeatedly in  one special  pair  of chromosomes.  10 leukemias  (15.6%) 
showed  the  presence  of  stemline(s)  with  trisomy  of  the  largest  telocentric 
chromosonle (C-1  trisomy). Another chromosome abnormality,  elongation of 
one of the pairs of the same chromosome (long C-I), was  found in 5 leukemias 
(7.8 %) as the predominant stemline and in 7 other cases as a small  cell popu- 
lation. This chromosome abnormality, despite slight differences in their elonga- 
tion rate, was defined as a new specific chromosome abnormality.  Other chro- 
mosome abnormalities not related with C-1  chromosome were found in 8 cases 
(12.5%). The remaining 41 leukemias  (64.1%) had the  predominant stemline 
with  normal  karyotype.  From  this  study  it  appears  that  three  structurally 
different hydrocarbon carcinogens, 7,12-dimethylbenz(a)anthracene  and 7,8, 
12-  and  6,8,12-trimethylbenz(a)anthracene act  on  blood-forming cells  by a 
common specific mechanism. 
4  Sugiyama, T. Unpublished data. TAKETOSHI SUGIYAMA AND  FILOMENA P.  BRILLANTES  341 
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